1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Type 1 Diabetes
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Decline of C-peptide during the first year after diagnosis of Type 1 diabetes in children and adolescents
(
- Contribution to journal › Article
-
Mark
Residual beta cell function at diagnosis of type 1 diabetes in children and adolescents varies with gender and season
(
- Contribution to journal › Article
- 2007
-
Mark
Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects
(
- Contribution to journal › Article
-
Mark
Islet cell autoantibody levels after the diagnosis of young adult diabetic patients
(
- Contribution to journal › Article
- 2000
-
Mark
Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus - A nationwide study
(
- Contribution to journal › Article
-
Mark
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
(
- Contribution to journal › Article
- 1999
-
Mark
Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus
(
- Contribution to journal › Article
- 1988
-
Mark
Factors influencing the magnitude, duration, and rate of fall of B-cell function in Type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis
(
- Contribution to journal › Article